1. ExecutiveSummary
2. United States Vaccines Market Size & Analysis (2015 - 2025)

3. United States Vaccines Market Share & Y-o-Y Growth (%), 2015 – 2025

4. Key Drivers and Inhibitors of the United States Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors

5. United States Top 21 Vaccines Market Assessment & Opportunity (Vaue),2015 – 2025

5.1 Prevnar/Prevnar 13
5.2 Gardasil/Gardasil 9
5.3 Fluzone
5.4 Varivax
5.5 Menactra
5.6 Proquad
5.7 Pneumovax 23
5.8 Fluarix/FluLaval
5.9 Havrix/Twinrix/Engerix-B
5.10 M-M-R II
5.11 Adacel
5.12 Boostrix
5.13 Bexsero
5.14 Menveo
5.15 Trumenba
5.16 Shingrix
5.17 Pentacel
5.18 Recombivax HB
5.19 Rotateq
5.20 Rotarix
5.21 Pediarix/Infanrix
5.22 Other Vaccines

6. United States Vaccines Pricing Trends & Analysis

7. United States Vaccines Regulatory System

8. Major Deals in United States Vaccines Market

8.1 Merger & Acquisitions
8.2 Collaboration Deal
8.3 Licensing Agreement
8.4 Exclusive Agreement
8.5 Distribution Agreement

9. Key Companies Analysis

9.1 Sanofi Pasteur
9.1.1 Business Overview
9.1.2 Promising Vaccines in Clinical Development
9.1.3 Recent Development
9.2 GlaxoSmithKline (GSK)
9.2.1 Business Overview
9.2.2 Promising Vaccines in Clinical Development
9.2.3 Recent Development
9.3 Merck
9.3.1 Business Overview
9.3.2 Promising Vaccines in Clinical Development
9.3.3 Recent Development
9.4 Pfizer
9.4.1 Business Overview
9.4.2 Promising Vaccines in Clinical Development
9.4.3 Recent DevelopmentList of Tables

Table 3–1: United States Vaccines Market Share & Y-o-Y Growth (Percent), 2015 - 2017
Table 3–2: United States Vaccines Market Share & Y-o-Y Growth Forecast (Percent), 2018 - 2025
Table 6–1: United States Adult Vaccines Price, 2018 – 2019
Table 6–2: United States Adult Influenza Vaccines Price, 2018 – 2019
Table 6–3: United States Pediatric Vaccines Price, 2018 – 2019
Table 6–4: United States Pediatric Influenza Vaccines Price, 2018 – 2019
Table 7–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 8–1: Merger & Acquisitions in Vaccines Market (Million US$),2003 – 2017
Table 8–2: Collaboration Deal in Vaccines Market,2007 – 2018
Table 8–3: Licensing Agreement in Vaccines Market,2007 – 2018
Table 8–4: Exclusive Agreement in Vaccines Market,2009 – 2016
Table 8–5: Distribution Agreement in Vaccines Market,2005 – 2016
Table 9–1: Sanofi Promising Vaccines in Clinical Development
Table 9–2: GSK Promising Vaccines in Clinical Development
Table 9–3: Merck Promising Vaccines in Clinical Development
Table 9–4: Pfizer Promising Vaccines in Clinical Development

List of Figures

Figure 2–1: United States Vaccines Market Size (Million US$),2015 - 2017
Figure 2–2: United States Vaccines Market Size Forecast (Million US$),2018 - 2025
Figure 5–1: United States Prevnar/Prevnar 13 Market Value (Million US$),2015 - 2017
Figure 5–2: United States Prevnar/Prevnar 13 Market Value Forecast (Million US$),2018-2025
Figure 5–3: United States Gardasil/Gardasil 9 Market Value (Million US$),2015 - 2017
Figure 5–4: United States Gardasil/Gardasil 9 Market Value Forecast (Million US$),2018 - 2025
Figure 5–5: United States Fluzone Market Value (Million US$),2015 - 2017
Figure 5–6: United States Fluzone Market Value Forecast (Million US$),2018 - 2025
Figure 5–7: United States Varivax Market Value (Million US$),2015 - 2017
Figure 5–8: United States Varivax Market Value Forecast (Million US$),2018 - 2025
Figure 5–9: United States Menactra Market Value (Million US$),2015 - 2017
Figure 5–10: United States Menactra Market Value Forecast (Million US$),2018 - 2025
Figure 5–11: United States Proquad Market Value (Million US$),2015 - 2017
Figure 5–12: United States Proquad Market Value Forecast (Million US$),2018 – 2025
Figure 5–13: United States Pneumovax 23 Market Value (Million US$),2015 - 2017
Figure 5–14: United States Pneumovax 23 Market Value Forecast (Million US$),2018 - 2025
Figure 5–15: United States Fluarix/FluLaval Market Value (Million US$),2015 - 2017
Figure 5–16: United States Fluarix/FluLaval Market Value Forecast (Million US$),2018 - 2025
Figure 5–17: United States Havrix/Twinrix/Engerix-B Market Value (Million US$),2015 - 2017
Figure 5–18: United States Havrix/Twinrix/Engerix-B Market Value Forecast (Million US$),2018 - 2025
Figure 5–19: United States M-M-R ll Market Value (Million US$),2015 - 2017
Figure 5–20: United States M-M-R ll Market Value Forecast (Million US$),2018 - 2025
Figure 5–21: United States Adacel Market Value (Million US$),2015 - 2017
Figure 5–22: United States Adacel Market Value Forecast (Million US$),2018 - 2025
Figure 5–23: United States Boostrix Market Value (Million US$),2015 - 2017
Figure 5–24: United States Boostrix Market Value Forecast (Million US$),2018 - 2025
Figure 5–25: United States Bexsero Market Value (Million US$),2015 - 2017
Figure 5–26: United States Bexsero Market Value Forecast (Million US$),2018 - 2025
Figure 5–27: United States Menveo Market Value (Million US$),2015 - 2017
Figure 5–28: United States Menveo Market Value Forecast (Million US$),2018 - 2025
Figure 5–29: United States Trumenba Market Value (Million US$),2015 - 2017
Figure 5–30: United States Trumenba Market Value Forecast (Million US$),2018 - 2025
Figure 5–31: United States Shingrix Market Value & Forecast (Million US$),2017 - 2025
Figure 5–32: United States Pentacel Market Value (Million US$),2015 - 2017
Figure 5–33: United States Pentacel Market Value Forecast (Million US$),2018 – 2025
Figure 5–34: United States Recombivax HB Market Value (Million US$),2015 – 2017
Figure 5–35: United States Recombivax HB Market Value Forecast (Million US$),2018 – 2025
Figure 5–36: United States Rotateq Market Value (Million US$),2015 – 2017
Figure 5–37: United States Rotateq Market Value Forecast (Million US$),2018 – 2025
Figure 5–38: United States Rotarix Market Value (Million US$),2015 – 2017
Figure 5–39: United States Rotarix Market Value Forecast (Million US$),2018 – 2025
Figure 5–40: United States Pediarix/Infanrix Market Value (Million US$),2015 – 2017
Figure 5–41: United States Pediarix/Infanrix Market Value Forecast (Million US$),2018 – 2025
Figure 5–42: United States Other Vaccines Market Value (Million US$),2015 – 2017
Figure 5–43: United States Other Vaccines Market Value Forecast (Million US$),2018 – 2025